70.88
2.42%
-1.76
Dopo l'orario di chiusura:
70.88
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché NUVL Giù?
Forum
Previsione
Nuvalent Inc Borsa (NUVL) Ultime notizie
Wedbush Reiterates Outperform Rating for Nuvalent (NASDAQ:NUVL) - Defense World
Defense World
Nuvalent director Conley Emily sells shares worth $345k - Investing.com
Investing.com
Wedbush Reaffirms "Outperform" Rating for Nuvalent (NASDAQ:NUVL) - MarketBeat
MarketBeat
Nuvalent’s NVL-655 Granted Breakthrough Therapy Designation By FDA - Contract Pharma
Contract Pharma
FDA grants breakthrough therapy status for Nuvalent's NVL-655 - Yahoo Finance
Yahoo Finance
Nuvalent, Inc. (NASDAQ:NUVL) Director Sells $2469000.00 in Stock - Defense World
Defense World
Nuvalent Receives U.S. FDA Breakthrough Therapy Designation for NVL-655 - Citizentribune
Citizentribune
FDA grants breakthrough status to Nuvalent's lung cancer drug By Investing.com - Investing.com
Investing.com
Nuvalent Receives U.S. FDA Breakthrough Therapy Designation for NVL-655 - BioSpace
BioSpace
Nuvalent gains breakthrough therapy status for non-small cell lung cancer candidate - Seeking Alpha
Seeking Alpha
Nuvalent Gets FDA Breakthrough Therapy Designation for Lung-Cancer Treatment - MarketWatch
MarketWatch
Nuvalent Receives U.S. FDA Breakthrough Therapy Designation for NVL-655 - PR Newswire
PR Newswire
Nicholas Investment Partners LP Cuts Position in Nuvalent, Inc. (NASDAQ:NUVL) - MarketBeat
MarketBeat
Nuvalent director Shair sells over $2.4 million in company stock - Investing.com
Investing.com
Nuvalent Inc [NUVL] Director makes an insider sale of 37500 shares worth $2.61 million. – Knox Daily - Knox Daily
Knox Daily
Insider Selling: Nuvalent, Inc. (NASDAQ:NUVL) Director Sells 37,500 Shares of Stock - MarketBeat
MarketBeat
Analysts Issue Forecasts for Nuvalent, Inc.'s Q1 2025 Earnings (NASDAQ:NUVL) - MarketBeat
MarketBeat
(NUVL) Technical Pivots with Risk Controls - Stock Traders Daily
Stock Traders Daily
Victory Capital Management Inc. Lowers Stake in Nuvalent, Inc. (NASDAQ:NUVL) - MarketBeat
MarketBeat
Analysts Set Nuvalent, Inc. (NASDAQ:NUVL) PT at $90.78 - MarketBeat
MarketBeat
Nuvalent, Inc. (NASDAQ:NUVL) Given Average Rating of “Moderate Buy” by Brokerages - Defense World
Defense World
Nuvalent Highlights Pipeline Progress, Reiterates Key Anticipated Milestones, and Reports First Quarter 2024 ... - Morningstar
Morningstar
Insider Selling: Nuvalent, Inc. (NASDAQ:NUVL) Director Sells 37,500 Shares of Stock - MarketBeat
MarketBeat
Nuvalent director Shair sells over $2.6 million in stock - Investing.com India
Investing.com India
Nuvalent director Shair sells over $2.6 million in stock - Investing.com
Investing.com
Why Earnings Season Could Be Great for Nuvalent (NUVL) - Yahoo Finance
Yahoo Finance
Why Earnings Season Could Be Great for Nuvalent (NUVL) - Zacks Investment Research
Zacks Investment Research
Insider Selling: Nuvalent, Inc. (NASDAQ:NUVL) Director Sells 37,500 Shares of Stock - MarketBeat
MarketBeat
Deborah Ann Miller Sells 3000 Shares of Nuvalent, Inc. (NASDAQ:NUVL) Stock - Defense World
Defense World
Nuvalent's chief legal officer sells over $200k in shares - Investing.com Australia
Investing.com Australia
Nuvalent's chief legal officer sells over $200k in shares - Investing.com Australia
Investing.com Australia
(NUVL) Investment Report - Stock Traders Daily
Stock Traders Daily
Insider Selling: Nuvalent, Inc. (NASDAQ:NUVL) Insider Sells 3,000 Shares of Stock - MarketBeat
MarketBeat
It makes sense and dollars to buy Nuvalent Inc (NUVL) stock – Sete News - SETE News
SETE News
Nuvalent director Shair sells over $2.6 million in company stock - Investing.com India
Investing.com India
Nuvalent director Shair sells over $2.6 million in company stock - Investing.com Canada
Investing.com Canada
Insider Selling: Shair Matthew, Nuvalent Inc [NUVL] Director divested 37500 shares – Knox Daily - Knox Daily
Knox Daily
(NUVL) Trading Report - Stock Traders Daily
Stock Traders Daily
Nuvalent Inc (NUVL) rating initates by Jefferies – Knox Daily - Knox Daily
Knox Daily
Nuvalent Inc (NUVL) presents a great opportunity, but the stock is slightly undervalued – US Post News - US Post News
US Post News
Jefferies bullish on Nuvalent stock, cites strong Phase 1 NSCLC trial results - Investing.com Nigeria
Investing.com Nigeria
Nuvalent Presents New Preclinical Data Supporting Profiles of HER2-Selective Inhibitor, NVL-330, and ROS1 ... - PR Newswire
PR Newswire
ARS Pharmaceuticals, Nuvalent, and More Stocks See Action From Activist Investors - Barron's
Barron's
Nuvalent director Matthew Shair sells over $2.8 million in company stock - Investing.com UK
Investing.com UK
Nuvalent director Matthew Shair sells over $2.8 million in company stock - Investing.com
Investing.com
Chief Legal Officer Deborah Miller Sells 22,000 Shares of Nuvalent Inc (NUVL) - Yahoo Finance
Yahoo Finance
Director Emily Conley Sells 13,333 Shares of Nuvalent Inc (NUVL) - Yahoo Finance
Yahoo Finance
S&P 500 Futures Climb in Premarket Trading; CrowdStrike Holdings, MicroStrategy Lead - Barron's
Barron's
Nuvalent to Present New Preclinical Data on HER2-Selective Inhibitor, NVL-330, and ROS1-Selective Inhibitor ... - PR Newswire
PR Newswire
Nuvalent Highlights Pipeline Progress, Reiterates Key Anticipated Milestones and Reports Fourth Quarter and Full ... - Yahoo Finance
Yahoo Finance
Capitalizzazione:
|
Volume (24 ore):